This work describes the functional characterization, cDNA cloning, and expression of a novel cell surface protein. This protein designated gClq-R, was first isolated from Raji cells and was found to bind to the globular "heads" of Clq molecules, at physiological ionic strength, and also to inhibit complement-mediated lysis of sheep erythrocytes by human serum. The NHzterminal amino acid sequence of the first 24 residues of the Clq-binding protein was determined and this information allowed the synthesis of two degenerate polymerase chain reaction primers for use in the preparation of a probe in the screening of a B cell cDNA library The cDNA isolated, using this probe, was found to encode a pre-pro protein of 282 residues. The NH2 terminus of the protein isolated from Raji cells started at residue 74 of the predicted pre-pro sequence. The cDNA sequence shows that the purified protein has three potential N-glycosylation residues and is a highly charged, acidic molecule. Hence, its binding to Clq may be primarily but not exclusively due to ionic interactions. The "mature" protein, corresponding to amino acid residues 74-282 of the predicted pre-pro sequence, was overexpressed in Escherichia coli and was purified to homogeneity This recombinant protein was also able to inhibit the complementmediated lysis of sheep erythrocytes by human serum and was shown to be a tetramer by gd filtration in nondissociating conditions. Northern blot and RT-PCR studies showed that the Clq-binding protein is expressed at high levels in Raji and Dandi cell lines, at moderate levels in U937, Molt-4, and HepG2 cell lines, and at a very low level in the HL60 call line. However, it is not expressed in the K562 cell line. Comparison of gClq-R NHz-terminal sequence with that of the receptor for the collagen-like domain ofClq (cClq-R) showed no similarity. Furthermore, antibodies to gClq-R or an 18-amino acid residue-long NHz-terminal synthetic gClq-R peptide did not cross-react with antibodies to cClq-R. Anti-gClq-R immunoblotted a 33-kD Raft cell membrane protein, whereas anti cClq-R recognized a molecule of ,v60 kD. The NH2-terminal sequence of gClg-R appears to be displayed extracdlularly since anti-gClg-R peptide reacted with surface molecules on lymphocytes, polymorphonudear leukocytes, and platelets, as assessed by flow cytometric and confocal laser scanning microscopic analyses. In addition, all or part of the gClq binding domain may reside within the 24 amino acid stretch of the NHz-terminal sequence of gClq-R since the 18 amino acid residue long-synthetic peptide corresponding to this region inhibited serum Clq hemolytic activity The data presented in this report suggest that there are at least two types of Clq-R which appear to be expressed on the same type of ceils and these receptors individually or in concert may contribute to the diversity of Clq-mediated responses.
of Clq (1) . This Clq receptor is a single chain, acidic glycoprotein with a molecular mass of",'60 kD (1) . However, this receptor has a rehtivdy low affinity to the collagen-like regions of Clq and binds at a very low ionic strength (10 mM potassium phosphate buffer) (17) . In 1989, a high affinity receptor, which binds to the globular heads of Clq, was reported to be present, along with the low ai~nity receptor, on human diploid fibroblasts (18) , thereby indicating that at least two types of Clq receptors might be involved to impart the vast array of Clq-mediated biologic functions.
In this paper and in a previous report (19) , a cell surface protein, which has a high affanity for the Clq globular heads, has been characterized. By the use of NHz-terminal protein sequence information and PCR techniques, a full-length cDNA done was isolated and the primary sequence of this protein has been predicted. Northern blot and RT-PCR studies were carried out to demonstrate the different levels of expression of this protein in different cell lines. Moreover, a recombinant form of this protein has been produced in Escherichia coli and shown to be able to inhibit complementmediated lysis of sheep erythrocytes by human serum.
Materiah and Methods

Chemicals and Reagents
The following chemicals and reagents were purchased from the sources indicated: FCS (Hydone Laboratories, Logan, UT); RPMI 1640, 100x antibiotic-antimycotic mixture (GIBCO BILL, Gaithersburg, MD); Emulphogene BC 720 (polyoxyethylene-10 tridecyl ether), FITC-conjugated goat anti-rabbit IgG, KLH, DMSO (Sigma Chemical Co., St. Louis, MO); NHS-LC-biotin (Sulfosuccinirnidyl-6-[biotinamido] Hexanoate), ImmunoPure A/G IgG purification kit, ImmunoPure horseradish peroxidase-conjugated goat anti-rabbit IgG, 4-chloro-l-naphthol, Tween 20 (Pierce, Rockford, IL); Con A-Sepharose PD-10 cohmns (Pharmacia, Biotech, Inc., Uppsah, Sweden); Mono-Q, TSKgd DEAE-NPK cohmns (TosoHaas, Montgomeryville, PA); mI-Na (Amersham, Aylesbury, UK); and polyvinylidene diiluoride (PVDF) membranes, (Immobilon-P; Millipore Corp., Bedford, MA),
Cultured Cells
Raji cells were used to prepare membrane proteins and were grown in R.PMI 1640 containing 10% (vol/vol) heat-inactivated (3 h, 56~ FCS and 1% (vol/vol) ofa 100x antibiotic-antimycotic mixture that consisted of 10,000 U/ml penicillin G, 25/~g/ml amphotericin B, and 100,000/~g/ml streptomycin sulfate and mainrained in an atmosphere of 95% air and 5% CO2. When large quantities of Raji cells were required, the cells were grown in 2-liter roller bottles as described earlier (20) . Other cell lines such as Dandi, U937, Molt-4, and HL60 were grown under similar conditions.
Purified Proteins
Human Clq used in these studies was purified by the method of Reid (21) . For comparison, Clq was also purified from a pool of freshly obtained sera according to the procedures of Yonemasu and Stroud (22) followed by purification on Con A-Sepharose 4B as described (23) .
The collagen "stalks" of Clq (cClq) were prepared by pepsin digestion of the purified Clq molecule following the procedure of Reid (24) and the globular "heads" of Clq were prepared by collagenase digestion as described (25) .
Radioiodination
Except for Clq, which was labeled by the method of Bolton and Hunter (26) , all other proteins were radiolabeled by the Iodogen method (27) with 1 mCi of Nal'~I as described elsewhere (3, 28) . After labeling, the free mI was removed by gel filtration using PD-10 (Sephadex G-25) columns equilibrated with the appropriate buffer system in which the labeled protein was to be kept.
Purification of r
The purification of Clq-R in these studies used a combination of two published methods (2, 3) with some minor modifications. These methods were: (a) alfinity purification on Clq-Sepharose CL-4B, (b) ion-exchange separation on FPLC using a Mono-Q column, and (c) HPLC purification using a TSKgel DEAE-NPR column as &scribed (3, 28) .
Clq--Sepharose Affinity Chromatography. Raji cell membranes were prepared from 20-1iter cultures (4 x 10 ~~ cells) as described in detail earlier (2, 20) . Half of the solubilized membrane solution was then applied to a column packed with 3 ml of Clq-Sepharose Cb4B (3 mg Clq/ml Sepharose) equilibrated with 10 mM sodium phosphate, pH 7.4, containing 20 mM NaCI, 0.1% Emulphogene BC720, and a cocktail of enzyme inhibitors (2, 20) . After washing (5 x cohnm volume), the bound proteins were eluted with the same buffer containing 1 M NaC1. The eluted material was dialyzed against equilibrating buffer, and a 0.5-ml aliquot was radiolabeled and then tested for Clq-binding activity by a solid phase radioligand binding assay described below. Preliminary studies showed that the eluted material contained most of the Clq-binding activity FPLC on Mono-Q Column. The Clq-binding material eluted from the Clq-Sepharose CL4B column was mixed with 100 td ('~106 cpm) of the radiohbded sample and applied to a 1-ml Mono-Q colunm (9, 17) . The column was washed until cpm/ml gl00, and then the bound proteins were eluted with a linear NaCI concentration gradient (0--600 mM NaC1). Clq-containing fractions were identified by solid phase binding assay (see below), pooled, and concentrated.
HPLC on DEAF. Column. The concentrated, Clq-binding fraction from the Mono-Q cohnm was dialyzed against 50 mM Tris, pH 8.0, and then subjected to HPLC using a 1-ml TSK gel DEAE-NPR column as described (9, 17) . The bound proteins were eluted using first a 0-500-mM NaCI gradient in equilibrating buffer (10 min) and then a 500 mM-1 M gradient (3 min).
Solid Phase Binding Assay
Sofid phase radioligand assays were performed using lzsI-hbeled Clq-R or Clq-R-enriched material by a previously described method (20, 29) . Briefly, 50/zl, 5/~g/ml each (15 raM NazCO3, 35 mM NaHCO3, pH 9.6) of Clq, cClq, or gClq were applied to duplicate wells of fiat-bottomed strip phte-8 (Costar Corp., Cambridge, MA) and incubated for 2 h at 37~ Wells coated with either 1%, BSA, 100/~g/ml IgG, or 100/~g/ml properdin, served as irrelevant or positively charged protein controls. After incubation, the wells were washed (3 x 300/~1) with TBST (50 mM "fi'is-HC1, pH 7.5, containing 150 mM NaC1 and 0.05% Tween 20) . Then 50/~1 of mI-labeled Clq-R in TBB (20 mM Tris-HCl, pH 7.5, containing 100/~g/rrd BSA) containing a fixed or increasing amounts of counts per minute were added and further incubated (1 h, 37"C). Next, the unbound radioactivity was removed, the wells washed (5 x 300 td) with "rBB, dried by tapping over a stack of filter papers, and the individual wells counted in a 3,-counter.
SDS-PAGE and Western Blot Analysis
SDS-PAGE analysis was performed on 1.5-mm-thick slab gels according to the method of Laemmli (30) . Samples were either run unreduced or reduced and alkyhted by boiling for 5 min in the presence of 0.1 M dithiothreitol and 0.2 M iodoacetamide. After running, the gels were stained with Coomassie Brilliant Blue, destained and dried. Gels containing radiolabeled samples were exposed to Kodak X-OMAT AR film at -800C and then analyzed by autoradiography. Samples for Western blot analysis (31) were first run on SDS-PAGE, then electrotransferred to polyvinyl difluoride (PVDF) nitrocellulose membranes, blocked with 5% nonfat milk containing TBST, and the bound proteins probed with predetermined dilutions of rabbit antibodies in the above buffer. The bound antibodies were visualized by horseradish peroxidase-conjugated goat anti-rabbit IgG followed by reaction with 4-chloro-l-naphthol substrate.
NHrtenninal Amino Acid Sequencing and Peptide Synthesis
The NH2-terminal sequence information of gClq-R was generated using a protein sequencer and analyzer (models 470A and 120A; Applied Biosystems, Inc., Foster City, CA) as described elsewhere (28, 32 ). An 18-amino acid residue-long synthetic peptide (gClqRts) derived from the NH2-terminal sequence of gClq-K was synthesized, on a peptide synthesizer (model 430A; Applied Biosystems, Inc.) at the Center for Analysis and Synthesis of Macromolecules (Department of Medicine, State University of New York, Stony Brook, NY). The peptide was then purified by gel filtration on HPLC.
Antibody Production
Antibody to gClq-R was prepared in rabbits according to the following schedule. Purified gClq-R (10-20/~g) in 200/~1 PBS was mixed with 200/tl each of complete and IFA and injected at three sites: one subcutaneous and two intramuscular. Booster injection was given as above 2 wk later and, thereafter, injections were made every 2 wk in IFA until a total of four such injections were made. The rabbits were then rested for 4-6 wk before a final injection was given and the rabbits bled and the serum collected and tested by ELISA against purified gClq-K.
Antibody to gClq-R peptide was generated by injection of 500 /~g of KLH-conjugated peptide following the immunization protocol described above. Conjugation of gClq-K peptide to KLH was accomplished by the glutaraldehyde method as described (33) . The IgG fraction from each antiserum was prepared using the ImmunoPure A/G IgG purification kit following the manufacturer's recommendations (Pierce). Antipeptide antibodies were further purified by affanity purification on KLH-Sepharose CL4B.
/zl GVB (Veronal-buffered saline, pH 7.4, containing 0.15 mM CaC12, 1 mM MgCh, and 0.1% gelatin). At the end of the incubation, the volume of the reaction mixtures was brought to 950 #1 GVK and 50 #1 of EA (10Vml, sheep erythrocytes [E] sensitized with IgM anti-sheep E [A]) was added and further incubated for 60 rain at 370C. The reaction was then stopped, immediately centrifuged, and free hemoglobin in the supernatant assessed spectrophotometrically at 412 nm.
Confocal Laser Scanning Microscopy
PBL, monocytes, and PMN were purified by a combination of Hcoll-HyFaque sedimentation (to separate PMNs from mononuclear cells) and plastic adherence in autologous serum (to separate monocytes from lymphocytes), as described (34) . For confocal hser scanning microscopic (CLSM) analyses, the celh were suspended at 106 celh/0.3 ml GVB (veronal-buffered saline, pH 7.4, containing 0.1% gelatin, 0.02% NAN3, and 5 ttg/ml cytochalasin B), preincubated for 30 min at 4"C with a 1:5 dilution of Clq-depleted and heatinactivated (56"C, 30 min) human serum to block Fc-K sites, and then incubated (1 h, 37"C or 40C) with 50/zl of a I mg/rrd each of either IgG anti gClq-K or IgG from preimmtme rabbit serum. After incubation, the cells were washed (2 x 2 ral) with cold GVB by centrifugation (800 g, 4"C), the pellet resuspended in 0.3 ml GVB and further incubated (1 h, 37"C or 4"C) with an appropriate dilution of HTC-conjugated goat anti-rabbit antibody. The cells were then washed (3 x 2 ml) in GVB resuspended in original volume and analyzed by CLSM.
cDNA Cloning and Overexpression of gClq-R
Generation of the First Strand eDNA from Raft Cell Total RNA by AMV Reverse Transcriptase. After purification of the Clq-binding protein, the sequence of the 24 NH2-terminal amino acids was determined by automated protein sequencing (Table I ). Based on this peptide, two degenerate PCK primers (BH-S and BH-3) ( Table 2) were designed and synthesized on a DNA synthesizer (modal 38LA; Applied Biosystems, Cheshire, UK). The antisense primer (BH-3) was used as the primer for the first strand cDNA synthesis from total RNA. All the components in the reverse transcription reaction were from a kit (cDNA Synthesis System Plus; Amersham International, Amersham, Bucks, UK), except for total KNA and primer. In a 10-#1 reaction: 3.0 ttl HzO; 2.0/A 5x first strand reaction buffer; 0.5 #1 sodium pyrophosphate solution; 0.5 p,l gNase inhibitor; 1.0/~1 deoxynudeoside triphosphate mix; 1.0/zl BH-3 primer (1/tg/rrd), 2.0/A Raji cell total RNA (10/~g/ttl); and 10 U AMV reverse transcriptase were mixed together. After incubation at 420C for 40 min, the tube was stored at -200C for subsequent PCK amplification. 
Hemolytic Assays
The effect of gClq-R18, KLH-gClq-R18, or the soluble, recombinant form of gClq-R (rgClq-R) was assessed by incubating various amounts of these molecules with 10/~1 normal human serum (NHS) 1 for 60 min at room temperature in a total volume of 100 The underlined sequence in gClq-R was used for the construction of two degenerate oligonucleotide probes as well as the generation of a synthetic peptide (gClq-RlS). a.a., amino acid; I, Inosine; ntd., nucleotide; R, A/G; Y, C/T.
Generation of the First Exact Match Oligonucleotide Probe by PCR Purification.
The first strand cDNA generated as described above was used as template and the two degenerate, inosine-containing oligonucleotides (BH-S and BH-3) were used as primers in the PCR reaction. A PCR reaction was performed with 30 cycles in a DNA thermal cycler (Perkin-Elmer/Cetus, Norwalk, CT) using a cycle of denaturation for 0.5 rain at 94~ annealing for 0.5 rain at 48~ and an extension at 72~ for 0.5 min. The reaction mixture (50 #1) contained 25 pmol of each primer, 0.25 mM dNTP, 1.25 U Taq polymerase (Promega, Southampton, OK) with the manufacturer's buffer system, together with 1.0/~1 first strand cDNA. The PCR product (5/~1) was ehctrophoresed on a 4% (wt/vol) agarose gd (Nusieve; FMC Bioproducts Europe, Vagensbaek, Denmark). The expected 66-bp product was obtained.
Subcloning and DNA Sequencing. After electrophoresis, the 66-bp fragment was cut out from the gel and extracted from the gel slice by centrifugation through glass wool (35) . The DNA fragment (6/~1 of duant) was bkmtend-ligated to the HincII site ofpBluescript SK (0.1/~g) using T4 DNA ligase (1 U, Amersham) in a 10-#1 reaction volume overnight at room temperature. The E. coli strain XI.-Blue 1 was used as the host in the transformation of cells with the ligation mixture. After transformation, the cells were plated on LAT plates (LB plates with 100/~g/ml ampicillin and 10/~g/ml tetracycline), which had been spread with X-Gal and isopropyl-B-D-thiogalactopyranoside (IFIG) several hours before the cells were inoculated. White colonies were screened by the PCR using the T7 and T3 primers and conditions as used previously Colonies that yielded the 246-bp PCR product (a 180-bp fragment was generated if there is no insert) were selected and the phsmids were purified by alkaline lysis method from a 10-ml miniprep culture. Doublestranded DNA sequencing was performed on two purified plasmids by the dideoxynucleotide chain termination procedure using T7 polymerase (Pharmacia).
Screening of the ~ gt 11 Human B Cell cDNA Library. Two oligonucleotide probes (KS-1 and KA-1, Table 2 ) were synthesized based on the DNA sequence of the clones generated by PCR. An EcoR1 site was added at the 5' end of each probe. These oligonucleotides were endlabeled with [3Zp]ATP using T4 kinase and were used to screen the library (,~106 plaques, Clonetech, Palo Alto, CA) separately, with KS-1 being used for first screening and KA-1 for second screening. Positive plaques were picked up and the phages were resuspended in 1 ml SM buffer (50 mM Tris-HC1, 10 mM NaC1, 10 mM MgSO4, and 0.01% gelatin). Screening of the positive plaques was performed by PCR reactions with primers KS-1 and the primers Fll or Rll in 25-/~1 reaction volumes. Fll (left arm) and Rll (right arm) were vector-specific primers. Cultures (10 ml) were grown from four positive plaques and )~ DNA was isohted by X mini kit (Qiagen Hybaid Ltd., Middlesex, OK). EcogI inserts were released by digestion, with EcoRI purified and subcloned into pBlueseript for sequence analysis. Three cDNA clones of 1.0-1.1 kb were sequenced by the dideoxynucleotide chain termination procedure using T7 polymerase.
Subcloning the eDNA Insert Encoding the gC1q-R into Plasmid pGex.
2T. First, a NcoI site was created in the pGex-2T plasmid (36) . pGex-2T plasmid was digested by Sinai, desphosphorylated by alkaline phosphatase, and ligated to a NcoI linker (10 met) by T4 DNA ligase. Plasmid (pGex-2TN) with the NcoI site inserted was selected, cultured, and purified by alkaline lysis method. Second, in order to create a NcoI site on the gClq-R protein insert for subdoning, a PCIL primer (BN-1) was synthesized. A 50-/~1 PCR reaction was carried out using BN-1 and T7P (a pBluescript primer) as primers andpBhescript containing the gClq-R eDNA insert as a temphte. PFU DNA polymerase (Promega) was used to rephce Taq polymerase so as to secure a high fidelity. The amplified PCIL product was then precipitated and digested by NcoI and BamH1. The digested insert was purified by gel and subcloned into the NcoI site and BamHI site of pGex-2TN. The phsmid that contained the right insert was isolated (pGex-2TNH) and transformed into E. coli strain NM554.
~pression of CIq-binding Protein (Residues 74-282 of the Amino Acid Sequence Predicted from the cDNA Clone) in E. coli Employing pGex-2T Vector.
A colony carrying pGex-2TNH was inoculated to a 100-ml LA (LB plus 50 mg/liter Ampicillin) and grown overnight at 37~ The next morning, the 100-ml culture was inoculated into 900 ml LA. After 1 h at 37~ protein expression was induced by 0.1 ram IIrI'G, the culture allowed to grow for 7 h at 37~ and the ceU harvested by centrifugation at 5,000 g for 15 min. For every liter of culture, 15 ml MTPBSN (150 mM NaCI, 16 mM NazI-IPO4, 4 mM NaHzPO~, 0.05% NAN3, 0.1% Triton X-100, pH 7.3) was used to resuspend the cell pellet. The cells were lysed by sonication (3 x 1 min) and the supernatant generated by centrifugation at 12,000 g for 15 min contained soluble proteins, including GST-gClq-R fusion product. Glutathione agarose beads (5 ml, sulphur linkage; Sigma Chemical Co.) were pre-pared by preswelling in MTPBSN, then washing twice in the same buffer. The supematant was allowed to pass through a column (10 mm x 150 ram) of the beads and the eluant was discarded. The column was washed by 50 ml MTPBSN to elute nonbinding proteius. The fusion protein was eluted by competition with free glutathione using 20 ml 50 mM Tris-HCl, pH 8.0, containing 5 mM reduced ghtathione (Sigma Chemical Co.) (final pH 7.5, freshly prepared). The ehent (20 ml) was made 150 mM with respect to NaC1 and 2.5 mM with CaClz before thrombin digestion. The concentration of the fusion protein at this stage was estimated to be 1.6 mg/ml. Thrombin was added to a concentration of 3.2/zg/ml and the digestion was allowed to proceed at room temperature for 2 h on a rotating platform. Complete digestion was achieved, as judged by SDS-PAGE carded out after reduction of disulfide bonds. A Mono-Q column (Pharmacia) was employed to purify the recombinant protein. The pH of the sample was adjusted by adding onetwentieth the volume of I M Tris, pH 8.6. The sample was applied to a Mono-Q column (1 ml) preeqnilibrated in buffer A (20 mM Tris, pH 8.5, 0.05% sodium azide) at a flow rate of 0.5 ml/min. A large peak which was not retained on the column, was collected and then the column was washed with buffer A containing 0.4 M NaC1 until the base line returned to zero. Another peak was eluted by buffer A containing 0.6 M NaCI. The two peaks were run on a 15% (wt/vol) SDS-PAGE under reducing conditions and the band giving the expected sequence of the gClq-R protein was determined, by NHz-terminal peptide sequencing to be in the peak eluted with buffer A containing 0.6 M NaC1.
Gel Filtration Chromatography. The recombinant protein and the markers were dialyzed into the gel filtration running buffer (50 mM Tris-HCl, 150 mM NaC1, 0.05% (wt/vol) NAN3, pH 7.5) and then loaded onto a Superose 12 column, which was connected to a FPLC system (Pharmacia). The molecular size markers employed were bovine IgG (160 kD), OVA (43 kD), soybean trypsin inhibitor (20.3 kD), and cytochrome C (12.4 kD).
Purification of Total RNA and Northern Blot Analysis. Total RNA (10/~g) from each sample was electrophoresed on a formaldehydecontaining 1% (wt/vol) agarose gel. After electrophoresis, the RNA was transferred to a Hybond-N membrane (Amersham) by capillary blotting and fixed onto the membrane by UV cross-linking (XL-1500 UV crosslinker; Spectronics Corporation, AMS, Burford, UK). A high specific activity, single strand DNA probe was generated by using the PCK method, with a 1.0-kb cDNA done as a template and the antisense primer, BM-1, using 30 cycles of denaturation for 0.5 min at 94~ annealing for 0.5 min at 53~ and an extension at 72~ for 0.5 min. The reaction mixture (50/zl) contained 25 pmol of the primer, 0.2 mM cold dATP, dTTP, and dGTP, 0.625 U Taq polymerase (Promega) with the manufacturer's buffer system, together with 2/zl tx-[a2p]dCTP (3,000 Ci/mmole, 10 mCi/ml).
After labeling, the probe was purified on a nick column (Pharmacia) and added directly to the formamide containing prehybridization buffer. The membrane was hybridized with the probe overnight at 42~ After hybridization, the filter was washed three times with 2x SSC, 0.1% SDS at room temperature, and then washed once in 0.1x SSC, 0.1% SDS at 65~ for 15 rain. The filter was exposed to x-ray film for 7 d at -70~
RT-PCR. First strand cDNA from various cell lines was generated from total RNAs and AMV reverse transcriptase as discussed above, except that oligo dT was used as primer. The first strand cDNAs were used as templates and the two oligonudeotides (KS-2 and BM-1) were used as primers in the PCR reaction. PCR reactions were performed with 30 cycles of denaturation for 0.5 min at 94~ annealing for 0.5 min at 53~ and an extension at 72~ for 45 s. The reaction mixture (50 #1) contained 25 pmol of each primer, 0.25 mM dNTP, 1.25 U Taq polymerase with the manufacturer's buffer system, together with 1.0/~1 first strand cDNA. The PCR product (5/zl) was dectrophoresed on a 2% (wt/vol) NuSieve agarose gel.
Results
Purification and Characterization of gC1q-R from Raji
Cells. The purification of gClqoR used sequentially, Clq-Sepharose CL-4B affinity chromatography (2), followed by FPLC on Mono-Q and then HPLC using a column of TSK gel DEAE-NPR (28, 32) . When the Clqobinding fraction from the FPLC Mono-Q column was subjected to purification on HPLC, the profile depicted in Fig. 1 was obtained. Fractions duting between 9 and 18 min were coated onto microtiter plates and tested for their ability to bind lz~I-Clq by the solid phase radioligand binding assay. Three major regions of activity were observed with the strongest Clq binding noted with fractions corresponding to peak 4. The position where the RO-SS/A-associated calreticulin is expected to dute is marked in Fig. 1 and is close to the position of cClq-R which duted at "~450 mM NaC1 (peak 1). Both of these molecules possess Clq-binding activity. To assess the structure and composition of the molecules contained within this region of Clq-binding activity, 250-#1 samples were taken from each region and analyzed by SDS-PAGE and autoradiography. As shown in the composite autoradiogram (inset, Fig. 1 ), peak 1 (inset A) contained a band of ~60 kD (nonreduced), which corresponds to the molecular weight of cClq-R; peak 2 (inset B) contained a 60-kD band and an additional 80-kD band; peak 3 (inset C) contained predominantly the 80-kD band (nortreduced) whereas peak 4 (inset D) consisted of a single band that migrated with an apparent molecular mass of 33 kD. Solid phase binding studies performed on the 33-kD molecule showed that it binds to Clq very strongly in a dose-dependent and saturable manner (Fig.  2) . Although the binding of this molecule to Clq is enhanced by low ionic strength conditions, significant binding (70%, n = 3) does occur even at physiologic ionic strength. Furthermore, whereas the binding of cClq-R and calreticulin to whole Clq was indistinguishable from each other, the binding of the 33-kD molecule was in general, two to three times higher than either the cClq-R or calreticulin (Fig. 2) . In addition, both the 60-and 80-kD species in peak 2 ( Fig.  1) appeared to bind to Clq as assessed by autoradiographic analysis of these proteins after elution from Clq-coated microtiter plates (data not shown).
The 33-kD Molecule Binds to Globular Heads of Clq.
To identify the domain of Clq to which the 33-kD molecule binds, solid phase binding studies were performed by binding lz~I-33 kD to microtiter plate wells coated with Clq, cClq, gClq, or BSA as described in Materials and Methods. As shown in Fig. 3 , the 33-kD molecule binds with high affinity to Clq and gClq but not to cClq, suggesting that it is a unique molecule with preferential binding to the globular heads of Clq. Because its elution position on the HPLC Figure 1 . HPLC profile of Clq-K purification. Solubilized Raji cell membranes were sequentially subjected to purification on Clq-Sepharose Cb4B and FPLC Mono-Q. Fractions containing Clq-binding activity were pooled and purified on HPLC using TSK gel DEAE-NPR column and proteins were eluted using concentration gradients of 0-500 mM NaC1 (10 rain) and 500 mM-1 M (3 rain). The positions of cClq-R, which ehited at ,,0450 mM NaC1 and gClq-R which eluted at about 700 mM NaCI are indicated. suggests this molecule to be highly acidic, an experiment was performed to demonstrate that the binding of this molecule to Clq, a basic protein, was not charge dependent. To this end, two very basic proteins, human IgG and properdin, were included in the binding assay and the binding of 12SI-gClq-R to these molecules compared with that of Clq and gClq. The result of a representative experiment (n = 3) is depicted in Fig. 4 and shows that lzSI-gClq-R binds to Clq and gClq but not to BSA, IgG, or properdin. Furthermore, gClq-R binds to Clq whose collagen stalks have been occupied by specific anti-stalks IgG (anti-cClq), whereas no binding was observed to IgG anti-cClq alone (Fig. 4) .
The NH2-terminal Sequence of gCIq-R Is Not Similar to that of cClq-R. To determine if the NH2-terminal amino
acid sequence of gClq-R shows any relationship to that of cClq-R., both molecules (i.e., peaks 1 and 4, Fig. 1 ) were subjected to NHz-terminal amino add sequence analyses. The results presented in Table 1 show that the two molecules do not appear to be related. Furthermore, within the 24 amino acid residues of the 33-kD gClq-R there are four aspartic acid and three glutamine acid residues suggestive of its acidic nature.
The NH2-terrainal Sequence of gClq-R Contains gC1q-Binding
Activity. In an effort to raise antipeptide antibody for affinity purification and immunochemical studies, an 18 amino acid residue-long synthetic peptide (gClq-Kls) of gClq-R in Table 1 ( 
66o
Amount of protein coated (ng/wel}) Figure 3 . Solid phase binding assay, gadiohbded gClq-g was incubated (2 h, 37~ with increasing concentrations of immobilized Clq, cClq, gClq, or BSA in PBS, pH 7.5. After incubation, individual walls were washed five times and counted. Each data point represents a mean of three separate experiments run in quadruplicate.
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with 10 #1 of NHS or GVB for I h at 37~ in a total volume of 100 t~g GVB. After incubation, the residual hemolytic activity was determined as described in Materials and Methods. Both the KLH-peptide and the gClq-Kts (data not shown) inhibited the hemolytic activity of NHS. Neither KLH alone nor irrelevant pepfides of similar length and charge as the gClq-Kts had such inhibitory activity.
Anti.gCIq.R and Antipeptide Antibodies Immunoblot a 33.kD Membrane Molecule+
Polyclonal antibodies raised against the 33-kD molecule and its 18 amino acid-NH2-terminal peptide were used in immunoblotting studies. These results shown in Fig. 5 demonstrate that both antibodies recognize the same membrane molecule which migrates with an approximate molecular mass of 33 kD.
CLSM Anal3nis Shows the 33.kD to Be Expressed on the Su~ace of Man 7 Peripheral Blood Cells.
To ascertain that gClq-R was a surface molecule, peripheral blood mononudear leukocytes were purified by Fieoll-Hypaque centrifugation as described Figm~ 4. Binding ofgClq-R to Clq andgClq is specific. Microtiter wells were coated with 500 ng each of either Clq or gClq; 1,000 ng each of properdin, rabbit anti-cClq IgG, or a preincubated mixture of Clq (500 rig) and anti-cClq IgG (1,000 rig) to form cClq-anti-cClq immune complex. After washing three times and blocking with 1% BSA-TBST, mIgClq-R was added, incubated (2 h, 37~ and analyzed as described above. The mean percent binding of three experiments run in duplicate is indicated above each bar. 
Isolation of a eDNA Clone Coding for the Clq-binding Protein.
Since the Clq-binding protein was isolated from the Raji call line, total RNA from Raji call was used as a template for first strand cDNA synthesis and subsequent PCR amplification, which employed primers BH-S and BH-3 ( Table  2) . A DNA fragment of the expected size (66 bp) was generated by PCR. This fragment was subdoned and three clones were sequenced. Based on the sequences, two exact match primers (KS-1 and KA-1) were synthesized for use in the screening of a ), gt 11 library. Three positive clones were isolated from the human B cell library and all were found to contain the same cDNA sequence (Fig. 7) . The longest clone was 1,139 bp long whereas the other two dones encompassed nucleotides 106-1113, found in the longest clone. The derived amino acid sequence (Pig. 7) confirms the protein sequencing data (amino acid sequence 74-97) and indicates that Figure 5 . Western blot analysis of Raji gClq-R. Solubilized Raji cell membrane proreins were analyzed by SDS-PAGE and Western blot analysis using anti-gClq-R (lane I), anti-peptide (lane 2), and antipeptide preabsorbed with KLH-Sepharose CL-4B (lane 3). A blot with rabbit IgG from preimmune serum was negative (data not shown).
the Clq-binding protein is synthesized as a pre-pro protein of 282 residues. The mature protein which starts at residue 74 is predicted from cDNA studies to be preceded by a 60 residue-long hydrophobic stretch containing five cysteines. This in turn is predicted to be preceded by a 13 residue-long leader peptide (37) . The predicted molecular weight of the 209 residue-long protein is 24.3 kD and contains three potential N-glycosylation sites at residues 114 (Asn-Gly-Thr), 136 (AshAsh-Set), and 223 (Asn-Tyr-Thr).
Northern Blot Analysis. Total RNA from various cell lines (38) was analyzed and is shown in Fig. 8 . After stringent washing (0.1 x SSC, 0.1% SDS, 65~ 15 rain) and exposure for 7 d, strong signals were seen in both B ceU lines (Daudi and Raji, Fig. 8) , whereas weaker signals could be seen in HepG2 and Molt-4 call lines. No signal was seen in K562 and only a smear could be seen in HL60. In another Northern blot carried out using the same conditions (data not shown), the U937 cell line (monocyte cell line) yielded a weaker signal than the Raji cell line but a comparable signal to that obtained with HepG2 and Molt-4 cell lines. The size of the mRNA for the Clq-binding protein is -1.5-1.6 kb.
RT-PCR.
Using primers BM-1 and KS-2, a PCR fragment of 468 bp should be generated from first strand cDNAs of positive cell lines. The PCR products were run into a 2% (wt/vol) NuSieve gel and the results are shown in Fig. 9 . In the positive control, plasmid containing the Clq-binding protein cDNA was used as template in the PCR reaction, whereas there is no first strand cDNA template in the negative control. There are strong signals in HepG2, Molt-4, Daudi, Raji, and U937 cells, but none in K562 cells. There is a weak signal from HL60, showing that it has a low level of the Clq-binding protein mRNA which is not detectable by Northern blotting. 4) is the transmitted light image of the sec= tion in (B), whereas (C) represents a composite image of (,4) and (B). The bottom panel is acom= posite of a series of 0.5-#m sections taken from the center of the cell ("equator") upwards to the "pole" (top left to right and bottom left to right).
Production of Recombinant Protein and its Properties. The
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C TCAGC ACAGC CCTGG AGCACCAGG~GTACATTAC TTTTCTTGAAGAC 900 t gaa~ctagacatgtgctttqaaat~attat catcctaat atcat gggggaaaa~ataccaaatttaaattat atgtt t tgtgt tct cat i080 t t at t atcat ttttt tctgt acaaatctat tattt ct agat t ttt~t at a~catgat ag mass of 27-28 kD on SDS-PAGE (even though the molecular weight calculated from the amino acid sequence is only 24.3 kD). In gel filtration studies using a Superose 12 column, the recombinant Clq-binding protein was eluted at a position corresponding to 97.2 kD which is consistent with it being a tetramer of a 24.3-kD polypeptide chain.
Recombinant gClq-R (rgClg-R) Inhibits Clq
Hemolytic Activity. The recombinant, sohble form of gClg-R generated by expression in E. coli was used to see its effect on Clq hemolytic activity in serum by incubating various concentrations of the recombinant molecule with NHS as described above. 
Recombinant gClq-R (~tg)
F i p n 10. Inhibition of serum hemolytic activity by recombinant gClq-K (rsClq-R). Various concentrations of rgClq-R were incubated with NHS as described in the legend to Fig. 5 and assessed for complement inhibitory activity.
As shown in Fig. 10 , the rgClq-R was capable of inhibiting the hemolytic activity of Clq in serum in a dose-dependent manner. To verify the specificity of this inhibition, rgClq-R was first preincubated with Clq before addition to Clqdepleted serum. Whereas, addition of Clq preincubated with rgClq-R did not reconstitute the hemolytic activity of Clqdepleted serum, the addition of Clq alone did, suggesting that addition of rgClq-R to serum indeed prevents the binding of Clq to immune complexes (data not shown). The gClq-R molecule does not, however, activate complement as assessed by C4 titration (data not shown). 
1818
Receptor for Globular "Heads"
Discussion
The existence of two distinct types of Clq receptors had been suggested earlier by Bordin et al. (6, 18) who showed that human diploid fibroblasts express a low a~nity Clq-R for the collagen-like domain and a small subpopulation expressing high affinity Clq-R which binds to the globular region of Clq. The present report describes the purification, functional characterization, cDNA cloning, and overexpression of this molecule henceforth referred to as the gClq-R.
The gClq-R molecule was isolated to homogeneity using the same purification procedures for cClq-R and employed a combination of two previously published methods (2, 28, 32) . Functional and immunochemical characterization of the gClq-R molecule revealed that: (a) it is a unique protein that does not share cross-reactive epitopes with cClq-R; (b) it binds with high affinity to the globular heads of Clq even when the collagen taft of Clq is saturated by anti-cClq IgG; (c) both the purified and recombinant forms of the molecule inof Clq hibit the hemolytic activity of Clq in serum and this inhibitory activity may reside within the 24 amino acid residues of the NHz terminus; and (d) anti-gClq-R antibodies blot a 33-kD molecule from Raji cells as well as other types of cells. Furthermore, CLSM analyses of peripheral blood monocytes and lymphocytes (Fig. 6 ) and other blood cells (8) with anti gClq-R antibodies show that gClq-R is expressed on the surface of these cells, although the degree of expression was found to differ from cell type to r type. These results indicate that gClq-R is coexpressed with cClq-R and is likely to be ubiquitously distributed (1) .
The cDNA for the Clq-binding protein encodes a pre-pro protein of 282 residues, as determined from the first methionine, whereas NHz-terminal sequence of the mature protein isolated from Raji cell begins with residue 74 (Leu) (Fig. 7) . It is uncertain if this is due to proteolytic cleavage during protein purification or if this protein has an unusually long signal peptide of 73 residues. It seems probable that residues 1-13, or 1-7, form the signal peptide of the Clq-binding protein since they give scores of 5.5 and 4.5, respectively, in the SIGCLEAVE command of the GCG program (39) . The mature protein (residues 74-282) is highly charged and is very acidic, with a calculated pI of 4.15. Out of 209 residues in the mature protein, there are 28 glutamic acid, 20 aspartic acid, 16 lysine, 5 histidine, and 4 arginine residues. In contrast, the first 73 residue-long stretch of the pre-pro protein does not have any glutamic acid, aspartic acid, lysine, or histidine residues, but does have 11 arginine residues. The mature protein has only one cystine and thus should not have any intra-chain disulfide bonding.
Since the mature protein contains many charged residues distributed all through the sequence, it is unlikely that it contains a transmembrane domain. Rather, the NHz-terminal 73 residue-long stretch, which is too long for a signal peptide, is more likely to contain a transmembrane and a cytoplasmic domain, in addition to a signal peptide. The mature protein purified from the Raji cell line has an apparent molecular mass of 33 kD in SDS-PAGE, much bigger than the calculated molecular weight from the primary sequence (24 kD). This could be explained partly by three potential N-glycosylation sites and partly by its highly acidic nature. For instance, although the recombinant protein has a calculated molecular mass of 24.3 kD and should be smaller than its fusion partner, ghtathione-S-transferase (26 kD), it had a larger apparent molecular weight ('~,27.5 kD) than GST. On the other hand, the recombinant protein behaved as a tetramer of the 24.3-kD polypeptide chain on gel filtration in nondissociating conditions, i.e., as a protein of 97.2 kD.
Northern blot studies and RT-PCIk showed that this protein was expressed in a variety of different types of cell lines. Daudi and Raji cells, which are both B cell lines, express a higher amount of mRNA than the other cell lines. The protein is also expressed in the U937 (a monocyte ceU line), Molt-4 (a T call line) and HepG2 cell lines (a hepatocyte cell line), but at a lower level than in the B cell lines. It was shown by RT-PCIL that HL-60 (a cell line derived from human promyelocytic leukemia, which is able to differentiate into nentrophil) expresses a low level of Clq-binding protein mRNA which was not detected by the Northern blotting study. However, both Northern blotting and RT-PCR confirmed that there is no expression in K562 cell line (a cell line derived from human myelogenous leukaemia, which is highly undifferentiated and of the granulocytic series). Furthermore, in previous studies (8, 19) , Western blot analyses showed that this protein is also expressed on eosinophils and neutrophils. On the other hand, a protein, apparently identical to the Clq-binding protein described in this paper, has been purified from HeLa cell line (a fibroblast cell line), and was initially identified as being a pre-mRNA splicing factor, designated as p32 or SF2 (40, 41) . However, the claims that it was a pre-mRNA splicing factor, were withdrawn by the same group in their subsequent paper (42) . The cDNA clone encoding p32 (41) lacked the first 90 nucleotides seen at the 5' end of the cDNA clone encoding the Clq-binding protein (Fig. 7) and, therefore, it was concluded that p32 lacked an initiating methionine and a signal peptide. However, both these features are seen in the amino acid sequence predicted for the Clq-binding protein (Fig. 7 ) and are consistent with this protein being secreted from the cell and found on the cell membrane.
Whether this novel molecule plays a primary or auxiliary role within the broad scheme of Clq-Clq-R interaction cannot be ascertained from the present studies. However, the existence of a multi-receptor system may explain in part the participation of Clq-R in such a vast array of cellular responses. It is shown that gClq-R is able to bind to the globular heads of Clq, even when it is associated with the Clrz-Cls2 complex. The binding of gClq-R to C1 complexes can inhibit the binding of C1 to IgM sensitized erythrocyte and thus block the lysis of the erythrocyte by complement. Of course, under in vivo conditions, the relative ratio of gClq-R and C1 is not the same as in in vitro experiments and, it is possible that C1 is able to bind to immune complexes, activate complement, and cross-link the immune complexes to the Clq-binding protein on effector cell surfaces, like B cell, T cell, monocytes, etc. The binding may result in various biological responses. That gClq-R participates in a variety of biological responses is evident from a number of experiments. Aggregated Clq-mediated phtelet activation which leads to the induction of Otlro/~3 integrins and expression of procoagcnlant activity (14) can be inhibited by either preincubation of the platelets with anti gClq-R antibody or, preexposure of the aggregated Clq with gClqRls (43) . In addition, the gClq-R and cClq-R, both of which are expressed on eosinophils, have been shown recently to mediate chemotaxis and chemokinesis (8) . These results clearly demonstrate that both receptors alone or in conjunction with other cell surface molecules are involved in various Clq-mediated cellular responses. Since the Clq molecule is postulated to circulate in plasma with its globular heads potentially available for binding, it is not clear how a gClq-R-bearing cell avoids binding to Clq. One possible hypothesis is that the conformational change of Clq followed by binding to cClg-R must take place before the gClq-R is engaged to induce secondary messages.
